Toll Free: 1-888-928-9744
Toll Free: 1-888-928-9744
Published: Oct, 2018 | Pages:
94 | Publisher: QYResearch
Industry: Healthcare | Report Format: Electronic (PDF)
In 2017, the global Anemia Drugs market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2018-2025.
This report focuses on the global Anemia Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Anemia Drugs development in United States, Europe and China.
The key players covered in this study
GlaxoSmithKline
Global Blood Therapeutics (GBT)
Bluebird Bio
GlycoMimetics
Mast Therapeutics
Fibrogen
Akebia Therapeutics
Bayer AG
Eli Lilly
Regen Biopharma
Acceleron Pharma
Celgene Corporation
Onconova Therapeutics
Pieris Pharmaceuticals
Market segment by Type, the product can be split into
Oral
Injection
Market segment by Application, split into
Iron Deficiency Anemia
Chronic Kidney Disease related Anemia
Sickle Cell Anemia
Aplastic Anemia
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Anemia Drugs status, future forecast, growth opportunity, key market and key players.
To present the Anemia Drugs development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Anemia Drugs are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Anemia Drugs Market Size Growth Rate by Type (2013-2025)
1.4.2 Oral
1.4.3 Injection
1.5 Market by Application
1.5.1 Global Anemia Drugs Market Share by Application (2013-2025)
1.5.2 Iron Deficiency Anemia
1.5.3 Chronic Kidney Disease related Anemia
1.5.4 Sickle Cell Anemia
1.5.5 Aplastic Anemia
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Anemia Drugs Market Size
2.2 Anemia Drugs Growth Trends by Regions
2.2.1 Anemia Drugs Market Size by Regions (2013-2025)
2.2.2 Anemia Drugs Market Share by Regions (2013-2018)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Anemia Drugs Market Size by Manufacturers
3.1.1 Global Anemia Drugs Revenue by Manufacturers (2013-2018)
3.1.2 Global Anemia Drugs Revenue Market Share by Manufacturers (2013-2018)
3.1.3 Global Anemia Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Anemia Drugs Key Players Head office and Area Served
3.3 Key Players Anemia Drugs Product/Solution/Service
3.4 Date of Enter into Anemia Drugs Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Anemia Drugs Market Size by Type (2013-2018)
4.2 Global Anemia Drugs Market Size by Application (2013-2018)
5 United States
5.1 United States Anemia Drugs Market Size (2013-2018)
5.2 Anemia Drugs Key Players in United States
5.3 United States Anemia Drugs Market Size by Type
5.4 United States Anemia Drugs Market Size by Application
6 Europe
6.1 Europe Anemia Drugs Market Size (2013-2018)
6.2 Anemia Drugs Key Players in Europe
6.3 Europe Anemia Drugs Market Size by Type
6.4 Europe Anemia Drugs Market Size by Application
7 China
7.1 China Anemia Drugs Market Size (2013-2018)
7.2 Anemia Drugs Key Players in China
7.3 China Anemia Drugs Market Size by Type
7.4 China Anemia Drugs Market Size by Application
8 Japan
8.1 Japan Anemia Drugs Market Size (2013-2018)
8.2 Anemia Drugs Key Players in Japan
8.3 Japan Anemia Drugs Market Size by Type
8.4 Japan Anemia Drugs Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Anemia Drugs Market Size (2013-2018)
9.2 Anemia Drugs Key Players in Southeast Asia
9.3 Southeast Asia Anemia Drugs Market Size by Type
9.4 Southeast Asia Anemia Drugs Market Size by Application
10 India
10.1 India Anemia Drugs Market Size (2013-2018)
10.2 Anemia Drugs Key Players in India
10.3 India Anemia Drugs Market Size by Type
10.4 India Anemia Drugs Market Size by Application
11 Central & South America
11.1 Central & South America Anemia Drugs Market Size (2013-2018)
11.2 Anemia Drugs Key Players in Central & South America
11.3 Central & South America Anemia Drugs Market Size by Type
11.4 Central & South America Anemia Drugs Market Size by Application
12 International Players Profiles
12.1 GlaxoSmithKline
12.1.1 GlaxoSmithKline Company Details
12.1.2 Company Description and Business Overview
12.1.3 Anemia Drugs Introduction
12.1.4 GlaxoSmithKline Revenue in Anemia Drugs Business (2013-2018)
12.1.5 GlaxoSmithKline Recent Development
12.2 Global Blood Therapeutics (GBT)
12.2.1 Global Blood Therapeutics (GBT) Company Details
12.2.2 Company Description and Business Overview
12.2.3 Anemia Drugs Introduction
12.2.4 Global Blood Therapeutics (GBT) Revenue in Anemia Drugs Business (2013-2018)
12.2.5 Global Blood Therapeutics (GBT) Recent Development
12.3 Bluebird Bio
12.3.1 Bluebird Bio Company Details
12.3.2 Company Description and Business Overview
12.3.3 Anemia Drugs Introduction
12.3.4 Bluebird Bio Revenue in Anemia Drugs Business (2013-2018)
12.3.5 Bluebird Bio Recent Development
12.4 GlycoMimetics
12.4.1 GlycoMimetics Company Details
12.4.2 Company Description and Business Overview
12.4.3 Anemia Drugs Introduction
12.4.4 GlycoMimetics Revenue in Anemia Drugs Business (2013-2018)
12.4.5 GlycoMimetics Recent Development
12.5 Mast Therapeutics
12.5.1 Mast Therapeutics Company Details
12.5.2 Company Description and Business Overview
12.5.3 Anemia Drugs Introduction
12.5.4 Mast Therapeutics Revenue in Anemia Drugs Business (2013-2018)
12.5.5 Mast Therapeutics Recent Development
12.6 Fibrogen
12.6.1 Fibrogen Company Details
12.6.2 Company Description and Business Overview
12.6.3 Anemia Drugs Introduction
12.6.4 Fibrogen Revenue in Anemia Drugs Business (2013-2018)
12.6.5 Fibrogen Recent Development
12.7 Akebia Therapeutics
12.7.1 Akebia Therapeutics Company Details
12.7.2 Company Description and Business Overview
12.7.3 Anemia Drugs Introduction
12.7.4 Akebia Therapeutics Revenue in Anemia Drugs Business (2013-2018)
12.7.5 Akebia Therapeutics Recent Development
12.8 Bayer AG
12.8.1 Bayer AG Company Details
12.8.2 Company Description and Business Overview
12.8.3 Anemia Drugs Introduction
12.8.4 Bayer AG Revenue in Anemia Drugs Business (2013-2018)
12.8.5 Bayer AG Recent Development
12.9 Eli Lilly
12.9.1 Eli Lilly Company Details
12.9.2 Company Description and Business Overview
12.9.3 Anemia Drugs Introduction
12.9.4 Eli Lilly Revenue in Anemia Drugs Business (2013-2018)
12.9.5 Eli Lilly Recent Development
12.10 Regen Biopharma
12.10.1 Regen Biopharma Company Details
12.10.2 Company Description and Business Overview
12.10.3 Anemia Drugs Introduction
12.10.4 Regen Biopharma Revenue in Anemia Drugs Business (2013-2018)
12.10.5 Regen Biopharma Recent Development
12.11 Acceleron Pharma
12.12 Celgene Corporation
12.13 Onconova Therapeutics
12.14 Pieris Pharmaceuticals
13 Market Forecast 2018-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2018-2025)
13.10 Market Size Forecast by Application (2018-2025)
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
List of Tables and Figures
Table Anemia Drugs Key Market Segments
Table Key Players Anemia Drugs Covered
Table Global Anemia Drugs Market Size Growth Rate by Type 2013-2025 (Million US$)
Figure Global Anemia Drugs Market Size Market Share by Type 2013-2025
Figure Oral Figures
Table Key Players of Oral
Figure Injection Figures
Table Key Players of Injection
Table Global Anemia Drugs Market Size Growth by Application 2013-2025 (Million US$)
Figure Iron Deficiency Anemia Case Studies
Figure Chronic Kidney Disease related Anemia Case Studies
Figure Sickle Cell Anemia Case Studies
Figure Aplastic Anemia Case Studies
Figure Anemia Drugs Report Years Considered
Table Global Anemia Drugs Market Size 2013-2025 (Million US$)
Figure Global Anemia Drugs Market Size and Growth Rate 2013-2025 (Million US$)
Table Global Anemia Drugs Market Size by Regions 2013-2025 (Million US$)
Table Global Anemia Drugs Market Size by Regions 2013-2018 (Million US$)
Table Global Anemia Drugs Market Share by Regions 2013-2018
Figure Global Anemia Drugs Market Share by Regions 2013-2018
Figure Global Anemia Drugs Market Share by Regions 2018
Table Market Top Trends
Table Global Anemia Drugs Revenue by Manufacturers (2013-2018) (Million US$)
Table Global Anemia Drugs Market Share by Manufacturers (2013-2018)
Figure Global Anemia Drugs Market Share by Manufacturers in 2018
Table Global Anemia Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Anemia Drugs Product/Solution/Service
Table Date of Enter into Anemia Drugs Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Anemia Drugs Market Size by Type (2013-2018) (Million US$)
Table Global Anemia Drugs Market Size Share by Type (2013-2018)
Figure Global Anemia Drugs Market Size Market Share by Type (2013-2018)
Table Global Anemia Drugs Market Size by Application (2013-2018) (Million US$)
Table Global Anemia Drugs Market Size Share by Application (2013-2018)
Figure Global Anemia Drugs Market Size Market Share by Application (2013-2018)
Figure Global Anemia Drugs Revenue Market Share by Application in 2017
Figure United States Anemia Drugs Market Size 2013-2018 (Million US$)
Table United States Key Players Anemia Drugs Revenue (2017-2018) (Million US$)
Table United States Key Players Anemia Drugs Market Share (2017-2018)
Table United States Anemia Drugs Market Size by Type (2013-2018) (Million US$)
Table United States Anemia Drugs Market Share by Type (2013-2018)
Table United States Anemia Drugs Market Size by Application (2013-2018) (Million US$)
Table United States Anemia Drugs Market Share by Application (2013-2018)
Figure Europe Anemia Drugs Market Size 2013-2018 (Million US$)
Table Europe Key Players Anemia Drugs Revenue (2017-2018) (Million US$)
Table Europe Key Players Anemia Drugs Market Share (2017-2018)
Table Europe Anemia Drugs Market Size by Type (2013-2018) (Million US$)
Table Europe Anemia Drugs Market Share by Type (2013-2018)
Table Europe Anemia Drugs Market Size by Application (2013-2018) (Million US$)
Table Europe Anemia Drugs Market Share by Application (2013-2018)
Figure China Anemia Drugs Market Size 2013-2018 (Million US$)
Table China Key Players Anemia Drugs Revenue (2017-2018) (Million US$)
Table China Key Players Anemia Drugs Market Share (2017-2018)
Table China Anemia Drugs Market Size by Type (2013-2018) (Million US$)
Table China Anemia Drugs Market Share by Type (2013-2018)
Table China Anemia Drugs Market Size by Application (2013-2018) (Million US$)
Table China Anemia Drugs Market Share by Application (2013-2018)
Figure Japan Anemia Drugs Market Size 2013-2018 (Million US$)
Table Japan Key Players Anemia Drugs Revenue (2017-2018) (Million US$)
Table Japan Key Players Anemia Drugs Market Share (2017-2018)
Table Japan Anemia Drugs Market Size by Type (2013-2018) (Million US$)
Table Japan Anemia Drugs Market Share by Type (2013-2018)
Table Japan Anemia Drugs Market Size by Application (2013-2018) (Million US$)
Table Japan Anemia Drugs Market Share by Application (2013-2018)
Figure Southeast Asia Anemia Drugs Market Size 2013-2018 (Million US$)
Table Southeast Asia Key Players Anemia Drugs Revenue (2017-2018) (Million US$)
Table Southeast Asia Key Players Anemia Drugs Market Share (2017-2018)
Table Southeast Asia Anemia Drugs Market Size by Type (2013-2018) (Million US$)
Table Southeast Asia Anemia Drugs Market Share by Type (2013-2018)
Table Southeast Asia Anemia Drugs Market Size by Application (2013-2018) (Million US$)
Table Southeast Asia Anemia Drugs Market Share by Application (2013-2018)
Figure India Anemia Drugs Market Size 2013-2018 (Million US$)
Table India Key Players Anemia Drugs Revenue (2017-2018) (Million US$)
Table India Key Players Anemia Drugs Market Share (2017-2018)
Table India Anemia Drugs Market Size by Type (2013-2018) (Million US$)
Table India Anemia Drugs Market Share by Type (2013-2018)
Table India Anemia Drugs Market Size by Application (2013-2018) (Million US$)
Table India Anemia Drugs Market Share by Application (2013-2018)
Figure Central & South America Anemia Drugs Market Size 2013-2018 (Million US$)
Table Central & South America Key Players Anemia Drugs Revenue (2017-2018) (Million US$)
Table Central & South America Key Players Anemia Drugs Market Share (2017-2018)
Table Central & South America Anemia Drugs Market Size by Type (2013-2018) (Million US$)
Table Central & South America Anemia Drugs Market Share by Type (2013-2018)
Table Central & South America Anemia Drugs Market Size by Application (2013-2018) (Million US$)
Table Central & South America Anemia Drugs Market Share by Application (2013-2018)
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Revenue in Anemia Drugs Business (2013-2018) (Million US$)
Figure GlaxoSmithKline Revenue Growth Rate in Anemia Drugs Business (2013-2018)
Table GlaxoSmithKline Recent Development
Table Global Blood Therapeutics (GBT) Company Details
Table Global Blood Therapeutics (GBT) Revenue in Anemia Drugs Business (2013-2018)(Million US$)
Figure Global Blood Therapeutics (GBT) Revenue Growth Rate in Anemia Drugs Business (2013-2018)
Table Global Blood Therapeutics (GBT) Recent Development
Table Bluebird Bio Company Details
Table Bluebird Bio Revenue in Anemia Drugs Business (2013-2018)(Million US$)
Figure Bluebird Bio Revenue Growth Rate in Anemia Drugs Business (2013-2018)
Table Bluebird Bio Recent Development
Table GlycoMimetics Company Details
Table GlycoMimetics Revenue in Anemia Drugs Business (2013-2018)(Million US$)
Figure GlycoMimetics Revenue Growth Rate in Anemia Drugs Business (2013-2018)
Table GlycoMimetics Recent Development
Table Mast Therapeutics Company Details
Table Mast Therapeutics Revenue in Anemia Drugs Business (2013-2018)(Million US$)
Figure Mast Therapeutics Revenue Growth Rate in Anemia Drugs Business (2013-2018)
Table Mast Therapeutics Recent Development
Table Fibrogen Company Details
Table Fibrogen Revenue in Anemia Drugs Business (2013-2018)(Million US$)
Figure Fibrogen Revenue Growth Rate in Anemia Drugs Business (2013-2018)
Table Fibrogen Recent Development
Table Akebia Therapeutics Company Details
Table Akebia Therapeutics Revenue in Anemia Drugs Business (2013-2018)(Million US$)
Figure Akebia Therapeutics Revenue Growth Rate in Anemia Drugs Business (2013-2018)
Table Akebia Therapeutics Recent Development
Table Bayer AG Company Details
Table Bayer AG Revenue in Anemia Drugs Business (2013-2018)(Million US$)
Figure Bayer AG Revenue Growth Rate in Anemia Drugs Business (2013-2018)
Table Bayer AG Recent Development
Table Eli Lilly Company Details
Table Eli Lilly Revenue in Anemia Drugs Business (2013-2018)(Million US$)
Figure Eli Lilly Revenue Growth Rate in Anemia Drugs Business (2013-2018)
Table Eli Lilly Recent Development
Table Regen Biopharma Company Details
Table Regen Biopharma Revenue in Anemia Drugs Business (2013-2018)(Million US$)
Figure Regen Biopharma Revenue Growth Rate in Anemia Drugs Business (2013-2018)
Table Regen Biopharma Recent Development
Table Acceleron Pharma Company Details
Table Celgene Corporation Company Details
Table Onconova Therapeutics Company Details
Table Pieris Pharmaceuticals Company Details
Table Global Anemia Drugs Market Size by Regions (Million US$) 2018-2025
Figure Global Anemia Drugs Market Size Share by Regions (2018-2025)
Figure Global Anemia Drugs Market Size Share by Regions in 2025
Figure United States Anemia Drugs Market Size Forecast (2018-2025)(Million USD)
Figure Europe Anemia Drugs Market Size Forecast (2018-2025)(Million USD)
Figure China Anemia Drugs Market Size Forecast (2018-2025)(Million USD)
Figure Japan Anemia Drugs Market Size Forecast (2018-2025)(Million USD)
Figure Southeast Asia Anemia Drugs Market Size Forecast (2018-2025)(Million USD)
Figure India Anemia Drugs Market Size Forecast (2018-2025)(Million USD)
Figure Central & South America Anemia Drugs Market Size Forecast (2018-2025)(Million USD)
Table Global Anemia Drugs Market Size by Product (2018-2025) (Million US$)
Figure Global Anemia Drugs Market Size by Product (2018-2025)
Figure Global Anemia Drugs Market Size by Product in 2025
Table Global Anemia Drugs Market Size by Application (2018-2025) (Million US$)
Figure Global Anemia Drugs Market Size by Application (2018-2025)
Figure Global Anemia Drugs Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.
